FDA GRAS "No Objection" for New Rebaudioside D

PureCircle Limited

("PureCircle")

PureCircle Receives FDA GRAS "No Objection" for New Rebaudioside D Stevia Sweetener

PureCircle (LSE: Pure,)the world's largest stevia supplier and marketer is pleased to announce that the United States Food and Drug Administration (FDA) has issued a No Objection letter for the use of PureCircle's Rebaudioside D (Reb D) as a general purpose sweetener for foods and beverages in the US. PureCircle research has identified high purity Reb D as having one of the best sweetness profiles of any steviol glycoside from the stevia leaf.

The clean sweetness of PureCircle's high purity Reb D has garnered broad commercial interest from customers seeking to develop naturally sweetened formulations with very low to no calories, particularly in food and beverages with higher sweetness levels, such as carbonated soft drinks. Its commercialization will play an important role in extending the company's breakthrough Stevia 3.0 innovation.

The GRAS confirmation of PureCircle's Reb D builds on the company's track record for bringing the latest stevia innovation to the market. With GRAS affirmation, PureCircle is prepared for immediate commercialization of Reb D.

Enquiries:

PureCircle Limited(www.purecircle.com)

Magomet Malsagov, CEO

+603 2166 2206

William Mitchell, CFO

+44 7974 005 163

RFC Corporate Finance (NOMAD)

+61 8 9480 2500

Steve Allen